Citigroup’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
Citigroup's FLNA Position: Q3 2026 in Review
Citigroup held its Filana Therapeutics (FLNA) position steady in Q3 2026 at 19 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #5765.
Citigroup first reported a position in FLNA in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.42M in Q3 2021. 80 funds tracked by Wall St. Rank hold FLNA as of Q3 2026.
- Citigroup held 19 shares of Filana Therapeutics worth $17 as of Q3 2026.
- Citigroup left its Filana Therapeutics share count unchanged in Q3 2026.
- Filana Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5765 holding.
- Citigroup first reported a position in Filana Therapeutics in Q2 2013 and has held it in 40 quarters since.
- Citigroup's Filana Therapeutics position peaked at $2.42M in Q3 2021.
- 80 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.